新帶狀皰疹疫苗(Shingles Vaccine)

現在美國有一種新的帶狀皰疹病毒疫苗Shingrix問世。 美國疾病控制中心(CDC) 强力建議所有50歲以上的人,不論是否長過水痘或得過带状疱疹,都需接种這種疫苗。 它的有效性高達97%,而舊的疫苗Zostavax有效性僅為51%,有效期為五至十年,對七十歲以上的老人它的有效性更低。
Past 31 days
Total Visit: 13
There are 2 fact-checking replies to the message
Asdfgh mark this message contains misinformation
originally written by Asdfgh
In adults 50 to 69 years old who got two doses, Shingrix was 97% effective in preventing shingles; among adults 70 years and older, Shingrix was 91% effective.

References

https://www.cdc.gov/vaccines/vpd/shingles/public/shingrix/index.html
重新來升等 mark this message contains true information
originally written by 重新來升等
的確有此建議,原文如下↓
CDC recommends Shingrix (recombinant zoster vaccine) as preferred over Zostavax® (zoster vaccine live) for the prevention of herpes zoster (shingles) and related complications. CDC recommends two doses of Shingrix separated by 2 to 6 months for immunocompetent adults age 50 years and older

References

https://www.cdc.gov/vaccines/vpd/shingles/hcp/shingrix/recommendations.html
Summary of Recommendations
Routine Vaccination of People 50 Years Old and Older

The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.

Add Cofacts as friend in LINE
Add Cofacts as friend in LINE
LINE 機器人
查謠言詐騙